Soumitra Ghosh

Life Sciences Consultant

1

Office Hours

How does this work?
Ask me about
Therapeutic Peptides
Peptide Therapy
Commercialization
R&D
Drug design
Drug discovery
Clinical research management
Clinical research
Work experience

Jun 2017 - Present

Abvance Therapeutics

Co-Founder and Scientific Advisor

logo

Jan 2015 - Present

Avexegen Therapeutics, Inc

Co-Founder and CSO

Feb 2014 - Present

Doon Associates LLC

President

Provide consulting services to pharmaceutical and biotechnology companies for metabolic and inflammatory disease indications in the areas of drug discovery and development, devices, drug delivery, R&D strategy, life cycle planning and intellectual property.

Jan 2011 - Present

Peptide Therapeutics Foundation

President

logo

Apr 2003 - Dec 2014

Amylin Pharmaceuticals Inc

Executive Director

Leader, Research Programs and Collaborations: Directed Amylin’s Research Team, and was responsible for day-to-day operations. Led research programs in peptide and protein-biologics-based drug discovery for metabolic disorders, mass spectrometry-based approaches for peptide hormone discovery, and research evaluation of external opportunities. Provided research support for Byetta®, Symlin®, Bydureon® and Myalept™ development programs and product commercialization. Member of Amylin's intellectual property strategy committee, and provided oversight for external R&D collaborations.

Jan 1994 - Dec 2003

MitoKor

Sr. Director, Chemical Biology

Led a multi-disciplinary group of scientists for: • small molecule drug discovery for osteoarthritis, obesity and neurodegenerative diseases • mitochondrial DNA haplotyping and genetic analysis for disease association studies. • development of proteomics technologies for mapping the mitochondrial proteome and new drug target identification

Talk to Soumitra

@ Copyright 2020 OfficeHours Technologies Co.